• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session

    8/2/22 12:41:45 PM ET
    $ACON
    $ALRN
    $AMTD
    $APDN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACON alert in real time by email

    Gainers

    • AMTD IDEA Group (NYSE:AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
    • Applied DNA Sciences, Inc. (NASDAQ:APDN) gained 166% to $1.8801 after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus.
    • ECMOHO Limited (NASDAQ:MOHO) jumped 117% to $0.2528.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) rose 56.2% to $75.00 after jumping 187% on Monday.
    • 36Kr Holdings Inc. (NASDAQ:KRKR) rose 51% to $1.92 after surging over 10% on Monday.
    • Berkshire Grey, Inc. (NASDAQ:BGRY) jumped 39% to $2.4900 after the company announced an expansion of its relationship with FedEx. The company has also granted FedEx a warrant to purchase common stock which vests incrementally.
    • Locafy Limited (NASDAQ:LCFY) rose 27.4% to $0.50. Locafy recently announced preliminary unaudited revenue for the financial year ended June 30.
    • Sientra, Inc. (NASDAQ:SIEN) gained 26.8% to $1.1817.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) jumped 25.6% to $3.48.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) gained 25.5% to $15.63 as the company posted a narrower-than-expected Q2 loss.
    • Nutex Health, Inc. (NASDAQ:NUTX) rose 25% to $3.60.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) rose 23.8% to $3.43.
    • Transocean Ltd. (NYSE:RIG) shares rose 23% to $3.96 after the company posted a narrower Q2 loss and announced $321 million contract for ultra-deepwater drillship deepwater conqueror.
    • L&F Acquisition Corp. (NASDAQ:LNFA) shares climbed 22% to $13.02.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 21.4% to $2.4286 after FF Top Holding and the company executed a non-binding term sheet for a proposed convertible term loan facility up to $600 million.
    • Moxian (BVI) Inc (NASDAQ:MOXC) gained 21.3% to $1.2129.
    • Aclarion, Inc. (NASDAQ:ACON) rose 21% to $1.1505.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) surged 20.2% to $3.99 following upbeat Q2 earnings.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 19.5% to $2.25 after dropping around 7% on Monday.
    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) gained 18.3% to $4.83. Quoin Pharmaceuticals recently announced receipt of constructive scientific advice from EMA for QRX003 development in Europe.
    • Vroom, Inc. (NASDAQ:VRM) jumped 18% to $1.7200.
    • Harsco Corporation (NYSE:HSC) gained 15.6% to $5.55 following Q2 earnings.
    • SunPower Corporation (NASDAQ:SPWR) rose 15.2% to $22.84 after the company reported better-than-expected Q2 sales results.
    • Renovacor, Inc. (NYSE:RCOR) surged 15.1% to $2.06.
    • Microvast Holdings, Inc. (NASDAQ:MVST) gained 15% to $3.06.
    • Uber Technologies, Inc. (NYSE:UBER) jumped 14.8% to $28.25 after the company reported better-than-expected Q2 sales results and reported gross bookings up 33% year over year.
    • Repligen Corporation (NASDAQ:RGEN) surged 14.6% to $243.65 after the company reported better-than-expected Q2 results and raised FY22 guidance.
    • Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) jumped 14.4% to $8.25. Lindblad Expeditions recently reported worse-than-expected Q2 EPS results.
    • Ostin Technology Group Co., Ltd. (NASDAQ:OST) rose 14.3% to $2.0108 after gaining 6% on Monday.
    • TravelCenters of America Inc. (NASDAQ:TA) jumped 14.1% to $48.44 after the company reported better-than-expected Q2 sales.
    • Root, Inc. (NASDAQ:ROOT) gained 13.3% to $1.19.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) rose 13.1% to $13.40. Virax Biolabs shares jumped 119% on Monday after New York City on Saturday declared monkeypox a public health emergency, which has lifted monkeypox-related stocks.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) rose 13% to $0.6749 after dipping around 22% on Monday.
    • Sunworks, Inc. (NASDAQ:SUNW) gained 13% to $2.4400.
    • Performance Shipping Inc. (NASDAQ:PSHG) rose 12.3% to $0.4049 after jumping over 30% on Monday. Performance Shipping recently entered into a time charter contract with Teekay Chartering Limited, with a gross charter rate of $23,000 per day for a period of roughly 24 months.
    • Lyft, Inc. (NASDAQ:LYFT) gained 11.7% to $15.53 in sympathy with Uber, which reported better-than-expected Q2 earnings results and announced that gross booking volume increased year over year.
    • Pinterest, Inc. (NYSE:PINS) rose 11.5% to $22.33 after Elliott Investment Management announced they are now Pinterest's largest investor. The company also reported Q2 financial results and issued Q3 guidance.
    • Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) gained 11.4% to $7.38 after the company reported upbeat quarterly earnings and said its Clio Subsidiary entered an agreement for the sale of its interests in five wireless partnerships to Verizon for $490 million.
    • JAKKS Pacific, Inc. (NASDAQ:JAKK) gained 10.7% to $24.51.
    • ZoomInfo Technologies Inc. (NASDAQ:ZI) rose 10.6% to $41.73 as the company reported better-than-expected results for its second quarter and also raised its revenue guidance for FY22.
    • Performance Shipping Inc. (NASDAQ:PSHG) gained 10.2% to $0.3968 after jumping more than 30% on Monday.
    • Berkeley Lights, Inc. (NASDAQ:BLI) jumped 9% to $4.9150.
    • So-Young International Inc.. (NASDAQ:SY) rose 6.5% to $0.8511.
    • Cryptyde, Inc. (NASDAQ:TYDE) rose 5.6% to $1.1409. Cryptyde, Inc. and Argo Energy recently announced Energy Program Development Agreement.
    • Conformis, Inc. (NASDAQ:CFMS) rose 5% to $0.2678. Conformis entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient's membership of healthcare facilities.


    Losers

    • Ontrak, Inc. (NASDAQ:OTRK) shares fell 44.3% to $0.7520 after the company announced a registered direct offering for aggregate gross proceeds of $4 million. The company is scheduled to report Q2 results on August 9.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares fell 37.1% to $8.17 after jumping 16% on Monday.
    • Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) dropped 30.2% to $6.33 after the company posted a wider Q2 loss.
    • FAT Brands Inc. (NASDAQ:FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.
    • DZS Inc. (NASDAQ:DZSI) fell 23% to $15.06 after the company reported worse-than-expected Q2 results.
    • FiscalNote Holdings Inc. (NYSE:NOTE) shares fell 17.1% to $7.05. FiscalNote completed acquisition of Aicel Technologies.
    • Syneos Health, Inc. (NASDAQ:SYNH) dipped 16.8% to $65.82 as the company lowered its FY22 guidance.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) shares declined 16.6% to $2.31. Better Therapeutics recently completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes.
    • TimkenSteel Corporation (NYSE:TMST) fell 16.4% to $16.49 after KeyBanc downgraded the stock from Overweight to Sector Weight.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) dropped 15.7% to $3.2779.
    • Aileron Therapeutics, Inc. (NASDAQ:ALRN) dipped 14.9% to $0.1363.
    • Daseke, Inc. (NASDAQ:DSKE) declined 14.6% to $7.34 following Q2 results.
    • Titan International, Inc. (NYSE:TWI) fell 14.4% to $14.52 following weak quarterly sales.
    • Oatly Group AB (NASDAQ:OTLY) dipped 14.4% to $3.3539 after the company reported worse-than-expected Q2 sales and issued FY22 sales guidance below estimates.
    • Enhabit, Inc. (NYSE:EHAB) dropped 13.9% to $15.47. Enhabit reported a 6.3% year-over-year decline in net service revenue.
    • Otonomy, Inc. (NASDAQ:OTIC) fell 13.8% to $0.2510. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
    • Kopin Corporation (NASDAQ:KOPN) declined 13.7% to $1.63 as the company reported second-quarter FY22 revenue growth of 20% year-on-year of $11.9 million, missing the consensus of $12.6 million.
    • Celyad Oncology SA (NASDAQ:CYAD) fell 13.7% to $2.1125. Calyad Oncology recently said that the FDA has lifted the clinical hold on the company's CYAD-101-002 Phase 1b trial after the company made changes to the eligibility criteria for the trial.
    • Emergent BioSolutions Inc. (NYSE:EBS) dropped 13.1% to $29.76 following downbeat quarterly results.
    • Astec Industries, Inc. (NASDAQ:ASTE) fell 11.4% to $43.38 after reporting a decline in quarterly earnings.
    • Woodward, Inc. (NASDAQ:WWD) dipped 10.2% to $94.12 after the company issued FY22 guidance below estimates. The company said its Q3 profitability was impacted by labor and material inflation as well as global supply chain and labor disruption.
    • Molson Coors Beverage Company (NYSE:TAP) fell 10.2% to $53.57 after the company reported worse-than-expected Q2 sales results.
    • Matson, Inc. (NYSE:MATX) fell 9.9% to $82.26 following Q2 results.
    • Avis Budget Group, Inc. (NASDAQ:CAR) dropped 9.1% to $164.66. Avis Budget reported better-than-expected Q2 EPS and sales results.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) fell 8.8% to $0.6799 after gaining around 18% on Monday.
    • Zebra Technologies Corporation (NASDAQ:ZBRA) dropped 8.8% to $326.73 after the company issued Q3 guidance below estimates.
    • Arconic Corporation (NYSE:ARNC) fell 8.6% to $27.82 as the company lowered its FY22 top-line outlook.
    • Sealed Air Corporation (NYSE:SEE) fell 8.4% to $56.31 following Q2 results.
    • Credit Acceptance Corporation (NASDAQ:CACC) dropped 8.3% to $533.62 after reporting Q2 results.
    • Credit Suisse Group AG (NYSE:CS) fell 5.5% to $5.45. Credit Suisse Group recently reported quarterly losses of 62 cents per share.
    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $ALRN
    $AMTD
    $APDN

    CompanyDatePrice TargetRatingAnalyst
    Molson Coors Beverage Company
    $TAP
    2/25/2026$42.00Neutral → Underperform
    BofA Securities
    Rhythm Pharmaceuticals Inc.
    $RYTM
    2/19/2026$478.00Outperform
    RBC Capital Mkts
    Transocean Ltd (Switzerland)
    $RIG
    2/18/2026$6.00Overweight → Equal Weight
    Barclays
    Pinterest Inc.
    $PINS
    2/13/2026$16.00Buy → Hold
    Deutsche Bank
    Pinterest Inc.
    $PINS
    2/13/2026$17.00Outperform → Sector Perform
    RBC Capital Mkts
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Outperform → Neutral
    Robert W. Baird
    Pinterest Inc.
    $PINS
    2/13/2026$19.00Buy → Neutral
    Citigroup
    More analyst ratings

    $ACON
    $ALRN
    $AMTD
    $APDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, which consolidates the financial results of The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE);  summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounte

    2/27/26 4:28:00 PM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    AMTD IDEA's Subsidiary AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD IDEA (NYSE:AMTD, SGX: HKB)) subsidiary AMTD Digital Inc. (NYSE:HKD), a NYSE‑listed company and subsidiary of AMTD Group Inc., today announced it has filed its annual report on Form 20‑F with the U.S. Securities and Exchange Commission for the fiscal year ended October 31, 2025. Summary highlights are below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on AMTD Digital's investor

    2/27/26 4:27:00 PM ET
    $AMTD
    $HKD
    Finance: Consumer Services
    Finance

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $ALRN
    $AMTD
    $APDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Llewellyn Lindsay Catherine sold $314,755 worth of shares (23,661 units at $13.30), decreasing direct ownership by 3% to 696,850 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/27/26 4:51:21 PM ET
    $LYFT
    Real Estate

    Director Ying Wei was granted 67,857 shares, increasing direct ownership by 23% to 368,789 units (SEC Form 4)

    4 - Microvast Holdings, Inc. (0001760689) (Issuer)

    2/25/26 6:55:11 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    Chief Legal & Bus Affairs Ofc. Walcott Wanjiku Juanita gifted 6,000 shares, decreasing direct ownership by 1% to 475,474 units (SEC Form 4)

    4 - PINTEREST, INC. (0001506293) (Issuer)

    2/25/26 5:28:47 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $ACON
    $ALRN
    $AMTD
    $APDN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VOQUEZNA TRIPLE PAK issued to PHATHOM PHARMACEUTICALS, INC

    Submission status for PHATHOM PHARMACEUTICALS, INC's drug VOQUEZNA TRIPLE PAK (ORIG-1) with active ingredient AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN has changed to 'Approval' on 05/03/2022. Application Category: NDA, Application Number: 215152, Application Classification: Type 1 - New Molecular Entity and Type 4 - New Combination

    5/11/22 10:51:07 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VOQUEZNA DUAL PAK issued to PHATHOM PHARMACEUTICALS, INC

    Submission status for PHATHOM PHARMACEUTICALS, INC's drug VOQUEZNA DUAL PAK (ORIG-1) with active ingredient AMOXICILLIN; VONOPRAZAN has changed to 'Approval' on 05/03/2022. Application Category: NDA, Application Number: 215153, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/11/22 10:17:03 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $ALRN
    $AMTD
    $APDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Molson Coors Brewing downgraded by BofA Securities with a new price target

    BofA Securities downgraded Molson Coors Brewing from Neutral to Underperform and set a new price target of $42.00

    2/25/26 7:40:17 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    RBC Capital Mkts initiated coverage on Rhythm Pharmaceuticals with a new price target

    RBC Capital Mkts initiated coverage of Rhythm Pharmaceuticals with a rating of Outperform and set a new price target of $478.00

    2/19/26 7:52:12 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Transocean downgraded by Barclays with a new price target

    Barclays downgraded Transocean from Overweight to Equal Weight and set a new price target of $6.00

    2/18/26 7:48:14 AM ET
    $RIG
    Oil & Gas Production
    Energy

    $ACON
    $ALRN
    $AMTD
    $APDN
    SEC Filings

    View All

    SEC Form 144 filed by Lyft Inc.

    144 - Lyft, Inc. (0001759509) (Subject)

    2/27/26 5:38:52 PM ET
    $LYFT
    Real Estate

    Enhabit Inc. filed SEC Form 8-K: Leadership Update

    8-K - Enhabit, Inc. (0001803737) (Filer)

    2/27/26 4:27:47 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Avis Budget Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AVIS BUDGET GROUP, INC. (0000723612) (Filer)

    2/27/26 4:15:37 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    $ACON
    $ALRN
    $AMTD
    $APDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    Chief Financial Officer Krishnamurthy Balaji (A) bought $1,599,780 worth of shares (22,453 units at $71.25), increasing direct ownership by 357% to 28,742 units (SEC Form 4)

    4 - Uber Technologies, Inc (0001543151) (Issuer)

    2/24/26 7:05:05 PM ET
    $UBER
    Real Estate

    Director Winnefeld James A Jr bought $4,901 worth of Class B Common Stock (100 units at $49.01), increasing direct ownership by 0.45% to 22,288 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    2/20/26 4:31:10 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    $ACON
    $ALRN
    $AMTD
    $APDN
    Leadership Updates

    Live Leadership Updates

    View All

    Pinterest Appoints Kecia Steelman to Board of Directors

    Pinterest, Inc. (NYSE:PINS) today announced that Kecia Steelman, President and Chief Executive Officer of Ulta Beauty, has been appointed to the company's Board of Directors, effective February 16, 2026. "Kecia is a seasoned executive with deep experience leading large-scale businesses and connecting consumers with brands they love," said Bill Ready, Chief Executive Officer of Pinterest. "Her track record of growing global businesses, building omnichannel experiences, and partnering closely with brands will be an asset as we continue to transform Pinterest into the leading visual discovery and AI-powered shopping platform, especially for Gen Z." Steelman joined Ulta Beauty in 2014 and h

    2/9/26 4:50:00 PM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    TTM Technologies, Inc. Appoints Two New Independent Directors

    SANTA ANA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global manufacturer of technology products, including mission systems, radio frequency ("RF") components and RF microwave/microelectronic assemblies, and technologically advanced interconnect solutions, including printed circuit boards ("PCB") and substrates, today announced that, after long and distinguished careers with TTM, Thomas Edman, the Company's former President and Chief Executive Officer and a current Class I member of the Board of Directors (the "Board"), and John Mayer, a current Class III member of the Board, will retire from the Board effective as of May 7, 2026, immediately

    2/2/26 7:00:00 AM ET
    $CACI
    $DCO
    $TTMI
    EDP Services
    Technology
    Military/Government/Technical
    Industrials

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    $ACON
    $ALRN
    $AMTD
    $APDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Lyft Inc.

    SC 13G/A - Lyft, Inc. (0001759509) (Subject)

    12/4/24 2:38:58 PM ET
    $LYFT
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Microvast Holdings Inc.

    SC 13D/A - Microvast Holdings, Inc. (0001760689) (Subject)

    11/21/24 9:41:30 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    $ACON
    $ALRN
    $AMTD
    $APDN
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    /C O R R E C T I O N -- Lindblad Expeditions Holdings, Inc./

    In the news release, Lindblad Expeditions Holdings, Inc. Reports 2025 Fourth Quarter and Full Year Financial Results, issued 26-Feb-2026 by Lindblad Expeditions Holdings, Inc. over PR Newswire, we are advised by the company that the conference call time is 9:00 a.m. Eastern Time on February 26, 2026 rather than 8:30 a.m. Eastern Time. The complete, corrected release follows: Lindblad Expeditions Holdings, Inc. Reports 2025 Fourth Quarter and Full Year Financial Results 2025 Delivered the Strongest Adjusted EBITDA Performance in Company HistoryHighlights:Total revenues increased 20% to $771.0 millionNet loss available to stockholders decreased $1.2 million to $34.6 million; including a $23.5

    2/26/26 7:30:00 AM ET
    $LIND
    Transportation Services
    Consumer Discretionary

    Lindblad Expeditions Holdings, Inc. Reports 2025 Fourth Quarter and Full Year Financial Results

    2025 Delivered the Strongest Adjusted EBITDA Performance in Company HistoryHighlights:Total revenues increased 20% to $771.0 millionNet loss available to stockholders decreased $1.2 million to $34.6 million; including a $23.5 million loss on extinguishment of debtAdjusted EBITDA increased 38% to $126.2 millionNet Yield per Available Guest Night increased 14% to $1,335 and Occupancy was 88%Refinanced long-term debt with $675.0 million of 7.00% senior secured notes, extending debt maturity to 2030, and increased the amount available under our revolving credit facility to $60.0 millionOn February 3, 2026, all outstanding Preferred Stock was converted into 9.0 million shares of Common StockNEW Y

    2/26/26 7:30:00 AM ET
    $LIND
    Transportation Services
    Consumer Discretionary